7rfr
From Proteopedia
(Difference between revisions)
m (Protected "7rfr" [edit=sysop:move=sysop]) |
|||
| (4 intermediate revisions not shown.) | |||
| Line 1: | Line 1: | ||
| - | '''Unreleased structure''' | ||
| - | + | ==Structure of SARS-CoV-2 main protease in complex with a covalent inhibitor== | |
| - | + | <StructureSection load='7rfr' size='340' side='right'caption='[[7rfr]], [[Resolution|resolution]] 1.63Å' scene=''> | |
| - | + | == Structural highlights == | |
| - | + | <table><tr><td colspan='2'>Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=7RFR OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=7RFR FirstGlance]. <br> | |
| - | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.626Å</td></tr> | |
| - | [[Category: | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=4W8:(1R,2S,5S)-N-{(1S,2S)-1-(1,3-benzothiazol-2-yl)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-3-(4-methoxy-1H-indole-2-carbonyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide'>4W8</scene></td></tr> |
| + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=7rfr FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=7rfr OCA], [https://pdbe.org/7rfr PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=7rfr RCSB], [https://www.ebi.ac.uk/pdbsum/7rfr PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=7rfr ProSAT]</span></td></tr> | ||
| + | </table> | ||
| + | __TOC__ | ||
| + | </StructureSection> | ||
| + | [[Category: Large Structures]] | ||
| + | [[Category: Ferre RA]] | ||
| + | [[Category: Gajiwala KS]] | ||
| + | [[Category: Liu W]] | ||
| + | [[Category: Stewart AE]] | ||
Current revision
Structure of SARS-CoV-2 main protease in complex with a covalent inhibitor
| |||||||||||
